SEGMENTED INFORMATION

12 Months Ended

Sep. 30, 2013

Segmented Information

NOTE 14. SEGMENTED INFORMATION

On November 4, 2011, the Company ceased all operations on its drug development business and adopted a new corporate development strategy that changed the business operation of the Company to digital media and digital education with an intense focus on China. Results of operations are reported on a consolidated basis for segment reporting purposes. Consolidated disclosures about revenue streams and long-lived assets by geographic area are seen below.

Revenues

The Company derived revenues from royalties and from consulting services for the year ended September 30, 2013, 2012 and 2011.

	Years ended September 30,
Revenue Stream	2013		2012		2011
Disposal of Indaflex rights (Mexico)	$	760,329	$	166,803	$	158,166
Consulting Fees (North America)		-		-		25,337
Gross Operating Revenue		760,329		166,803		183,503
Other non-operating revenue:
Forgo Salary		106,377		117,300		-
Gain from disposal of fixed assets		-		67,077		-
Legal Settlement		-		59,949		-
Interest Income		2,704		683		-
Total Revenues and Non-Operating Revenues	$	869,410	$	411,812	$	183,503
	Years ended September 30,
Long Lived Assets		2013		2012		2011
North America	$	-	$	-	$	9,790
Asia		20,518		-		-
Total Long Lived Assets	$	20,518	$	-	$	9,790